Thanks for the feedback.
I agree to most of your optimism and I beleive in the same except the very first line "There will be NO CR ahead of FDA (likely) approval".
Problem with this approach is that MSB is taking a huge risk getting so close to approval with low funds that just in case it gets delayed for few months (always a possibility) that SP will fall so bad and they'll be in a dire situation of raising funds with extreme dilution (if they are able to raise at all in such a low sentiment).
Don't forget that last raise was at 30cents. It was a extreme blow of dilution to investors who didn't/couldn't buy at that price.
Ann: Annual Financial Results Presentation, page-19
-
- There are more pages in this discussion • 192 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |